share_log

SEI Inv Analyst Ratings

SEI Inv Analyst Ratings

SEI Inv 分析師評級
Benzinga ·  2023/10/26 08:31
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
10/26/2023 12.13% Morgan Stanley $63 → $61 Maintains Underweight
10/05/2023 25% Oppenheimer $71 → $68 Maintains Outperform
10/03/2023 17.65% Piper Sandler $65 → $64 Maintains Neutral
10/03/2023 15.81% Morgan Stanley $65 → $63 Maintains Underweight
07/27/2023 25% Keefe, Bruyette & Woods $66 → $68 Maintains Market Perform
07/27/2023 19.49% Morgan Stanley $62 → $65 Maintains Underweight
07/05/2023 30.51% Oppenheimer $68 → $71 Maintains Outperform
07/05/2023 13.97% Morgan Stanley $60 → $62 Maintains Underweight
06/01/2023 10.29% Morgan Stanley $58 → $60 Maintains Underweight
04/04/2023 25% Oppenheimer → $68 Reiterates → Outperform
04/03/2023 6.62% Morgan Stanley $54 → $58 Maintains Underweight
03/29/2023 10.29% Piper Sandler → $60 Initiates Coverage On → Neutral
02/01/2023 -0.74% Morgan Stanley $53 → $54 Maintains Underweight
01/26/2023 25% Oppenheimer $65 → $68 Maintains Outperform
12/01/2022 -2.57% Morgan Stanley $51 → $53 Maintains Underweight
11/23/2022 15.81% Goldman Sachs $56 → $63 Maintains Neutral
11/16/2022 23.16% Oppenheimer $59 → $67 Maintains Outperform
10/04/2022 -6.25% Morgan Stanley $52 → $51 Maintains Underweight
07/21/2022 -4.41% Morgan Stanley $55 → $52 Maintains Underweight
07/15/2022 1.1% Keefe, Bruyette & Woods $62 → $55 Maintains Market Perform
07/12/2022 Morgan Stanley Downgrades Equal-Weight → Underweight
07/06/2022 1.1% Morgan Stanley $58 → $55 Maintains Equal-Weight
06/02/2022 6.62% Morgan Stanley $62 → $58 Maintains Equal-Weight
04/21/2022 13.97% Morgan Stanley $68 → $62 Maintains Equal-Weight
03/28/2022 19.49% Goldman Sachs $67 → $65 Downgrades Buy → Neutral
03/28/2022 25% Morgan Stanley $75 → $68 Maintains Equal-Weight
01/27/2022 28.68% Oppenheimer $75 → $70 Maintains Outperform
11/03/2021 23.16% Truist Securities → $67 Initiates Coverage On → Hold
11/02/2021 23.16% Truist Securities → $67 Initiates Coverage On → Hold
07/22/2021 37.87% Oppenheimer $72 → $75 Maintains Outperform
04/22/2021 36.03% Morgan Stanley $75 → $74 Maintains Equal-Weight
04/01/2021 37.87% Morgan Stanley $74 → $75 Maintains Equal-Weight
01/28/2021 36.03% Morgan Stanley $72 → $74 Maintains Equal-Weight
01/06/2021 29.6% Goldman Sachs → $70.5 Initiates Coverage On → Buy
11/30/2020 32.35% Morgan Stanley → $72 Downgrades Overweight → Equal-Weight
10/06/2020 15.81% Morgan Stanley → $63 Initiates Coverage On → Overweight
04/24/2020 6.62% Oppenheimer $60 → $58 Maintains Outperform
04/15/2019 Keefe, Bruyette & Woods Downgrades Outperform → Market Perform
日期 上行/下行 分析公司 目標價格變化 評級變化 上一次/當前評級
2023年10月26日 12.13% 摩根士丹利 $63→$61 維護 體重不足
10/05/2023 25% 奧本海默 $71→$68 維護 跑贏大盤
10/03/2023 17.65% 派珀·桑德勒 $65→$64 維護 中性
10/03/2023 15.81% 摩根士丹利 $65→$63 維護 體重不足
07/27/2023 25% Keefe,Bruyette&Wood $66→$68 維護 市場表現
07/27/2023 19.49% 摩根士丹利 $62→$65 維護 體重不足
07/05/2023 30.51% 奧本海默 $68→$71 維護 跑贏大盤
07/05/2023 13.97% 摩根士丹利 $60→$62 維護 體重不足
06/01/2023 10.29% 摩根士丹利 $58→$60 維護 體重不足
04/04/2023 25% 奧本海默 →$68 重申 →跑贏大盤
04/03/2023 6.62% 摩根士丹利 $54→$58 維護 體重不足
03/29/2023 10.29% 派珀·桑德勒 →$60 開始承保 →中性
02/01/2023 -0.74% 摩根士丹利 $53→$54 維護 體重不足
2023年1月26日 25% 奧本海默 $65→$68 維護 跑贏大盤
12/01/2022 -2.57% 摩根士丹利 $51→$53 維護 體重不足
2022年11月23日 15.81% 高盛 $56→$63 維護 中性
2022年11月16日 23.16% 奧本海默 $59→$67 維護 跑贏大盤
10/04/2022 -6.25% 摩根士丹利 $52→$51 維護 體重不足
07/21/2022 -4.41% 摩根士丹利 $55→$52 維護 體重不足
07/15/2022 1.1% Keefe,Bruyette&Wood $62→$55 維護 市場表現
07/12/2022 - 摩根士丹利 評級下調 等重→減碼
07/06/2022 1.1% 摩根士丹利 $58→$55 維護 等重
06/02/2022 6.62% 摩根士丹利 $62→$58 維護 等重
04/21/2022 13.97% 摩根士丹利 $68→$62 維護 等重
03/28/2022 19.49% 高盛 $67→$65 評級下調 購買→中性
03/28/2022 25% 摩根士丹利 $75→$68 維護 等重
2022年01月27日 28.68% 奧本海默 $75→$70 維護 跑贏大盤
11/03/2021 23.16% Truist證券 →$67 開始承保 →保留
11/02/2021 23.16% Truist證券 →$67 開始承保 →保留
07/22/2021 37.87% 奧本海默 $72→$75 維護 跑贏大盤
04/22/2021 36.03% 摩根士丹利 $75→$74 維護 等重
04/01/2021 37.87% 摩根士丹利 $74→$75 維護 等重
2021年1月28日 36.03% 摩根士丹利 $72→$74 維護 等重
01/06/2021 29.6% 高盛 →$70.5 開始承保 →購買
11/30/2020 32.35% 摩根士丹利 →$72 評級下調 超重→等重
10/06/2020 15.81% 摩根士丹利 →$63 開始承保 →超重
04/24/2020 6.62% 奧本海默 $60→$58 維護 跑贏大盤
2019年04月15日 - Keefe,Bruyette&Wood 評級下調 跑贏→市場表現

What is the target price for SEI Inv (SEIC)?

SEI Inv(SEIC)的目標價是多少?

The latest price target for SEI Inv (NASDAQ: SEIC) was reported by Morgan Stanley on October 26, 2023. The analyst firm set a price target for $61.00 expecting SEIC to rise to within 12 months (a possible 12.13% upside). 17 analyst firms have reported ratings in the last year.

納斯達克(Sequoia Inv:SEIC)的最新目標價是摩根士丹利在2023年10月26日報道的。這家分析公司將目標價定為61.00美元,預計SEIC將在12個月內上漲(可能上漲12.13%)。過去一年,17家分析公司公佈了評級。

What is the most recent analyst rating for SEI Inv (SEIC)?

SEI Inv(SEIC)的最新分析師評級是多少?

The latest analyst rating for SEI Inv (NASDAQ: SEIC) was provided by Morgan Stanley, and SEI Inv maintained their underweight rating.

納斯達克(Sequoia Capital:SEIC)的最新分析師評級由摩根士丹利提供,SEI Inv維持其減持評級。

When is the next analyst rating going to be posted or updated for SEI Inv (SEIC)?

SEI Inv(SEIC)的下一次分析師評級將於何時發佈或更新?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of SEI Inv, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for SEI Inv was filed on October 26, 2023 so you should expect the next rating to be made available sometime around October 26, 2024.

分析師在進行了廣泛的研究後得出了股票評級,這些研究包括查閱公共財務報表,與SEI Inv的高管和客戶交談,以及收聽收益電話會議。大多數分析師每三個月就會這樣做一次,所以你每年應該會得到每家公司每家公司的4個評級。SEI Inv的上一次評級是在2023年10月26日提交的,因此您應該預計下一次評級將在2024年10月26日左右提供。

Is the Analyst Rating SEI Inv (SEIC) correct?

分析師評級SEI Inv(SEIC)正確嗎?

While ratings are subjective and will change, the latest SEI Inv (SEIC) rating was a maintained with a price target of $63.00 to $61.00. The current price SEI Inv (SEIC) is trading at is $54.40, which is out of the analyst's predicted range.

雖然評級是主觀的,並將發生變化,但最新的SEI Inv(SEIC)評級維持不變,目標價在63.00美元至61.00美元之間。SEI Inv(SEIC)目前的交易價格為54.40美元,超出了分析師的預測區間。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論